日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

TLR9-activating cholesterol azetidine derivative-assisted therapeutic vaccines for cancer immunotherapy.

TLR9激活胆固醇氮杂环丁烷衍生物辅助的癌症免疫治疗疫苗。

Chen Junbin, Su Miao, Yu Boya, Yang Mingda, Wang Huiye, Yang Xianzhu, Wang Jun

Multiomics identifies a cholesterol-TFEB-PLD3-TLR9 axis driving immunosuppressive tumor-associated macrophage polarization in esophageal squamous cell carcinoma

多组学分析发现,胆固醇-TFEB-PLD3-TLR9轴驱动食管鳞状细胞癌中免疫抑制性肿瘤相关巨噬细胞的极化。

Tan, Licheng; Zhou, Hongyu; Zhang, Baifeng; Kwong, Dora Lai Wan; Jia, Yongxu; Huang, Jiayi; Siu, Kin To Hugo; Zhang, Shuang; Huang, Jiao; Luo, Jie; Yang, Yuma; Liu, Qin; Lyu, Yingchen; Ban, Liuxian; Qi, Ziyang; Yu, Nanzhou; He, Chaohui; Zhang, Weiguang; Qin, Yanru; Liu, Beilei; Guan, Xinyuan

Nanostructured branched Y-DNA promotes antitumor immunity through dual activation of cGAS/STING and TLR9

纳米结构分支Y-DNA通过双重激活cGAS/STING和TLR9促进抗肿瘤免疫

Seok, Jin Kyung; Jee, Jung In; Oh, Jong Han; Ahn, So Yeon; Cho, Hana; Yang, Young Eun; Kim, Minhyuk; Kwon, Hyung-Joo; Cho, Yong-Yeon; Lee, Hye Suk; Um, Soong Ho; Kang, Han Chang; Lee, Joo Young

Altered Erythrocyte Function via TLR9-ox-mtDNA Binding Links Mitochondrial Oxidative Damage to Systemic Inflammation in Multiple Sclerosis

TLR9-ox-mtDNA结合导致红细胞功能改变,从而将线粒体氧化损伤与多发性硬化症的全身炎症联系起来

Yang, Lingfei; Hao, Qianmeng; Chen, Yufei; Xu, Yudi; Chen, Ziyi; Li, Qingsheng; Yao, Yaobing; Gong, Zhe; Liu, Huimin; Qin, Hongzhuo; Li, Yanfei; Jia, Yanjie

Simultaneous detection of lymphocytes and tumor cells in vivo in response to STING-TLR9 immunotherapy with Raman active multiplexed gold nanostars

利用拉曼活性多重金纳米星同时检测体内STING-TLR9免疫疗法诱导的淋巴细胞和肿瘤细胞

Kothadiya, Siddhant; Cutshaw, Gabriel P; Mathew, Ansuja P; Zielinski, Casey; Bardhan, Rizia

Phosphorothioate Backbone Modification of Oligodeoxynucleotides Induces TLR9-Independent Lung Epithelial Antimicrobial Responses

寡脱氧核苷酸的硫代磷酸酯骨架修饰诱导不依赖于TLR9的肺上皮抗菌反应

Wang, Yongxing; Kulkarni, Vikram V; Pantaleón García, Jezreel; Ntita, Mbaya; Chavez Cavazos, Miguel; Reese, Tanner C; Liu, Yun; Vila Ellis, Lisandra; Tuvim, Michael J; Evans, Scott E

Stoking an anti-liver cancer immune response with cryoablation plus an intratumoral TLR9 agonist and dual checkpoint inhibitors.

采用冷冻消融术联合肿瘤内 TLR9 激动剂和双重检查点抑制剂来激发抗肝癌免疫反应。

Yang Yunpeng, Mandt Tyler, Mittelstein David, Das Manasi, Wu Panyisha, Ghani Mansur A, Illindala Ritvik, Steinmetz Nicole F, Burgoyne Adam M, Berman Zachary, Webster Nicholas, Newton Isabel G

TLR9 Inhibition Shortly After Mating Increases Fetal Resorption and Alters B- and T-Cell Costimulatory Phenotypes in an Abortion-Prone Mouse Model

交配后不久抑制TLR9可增加易流产小鼠模型中的胎儿吸收并改变B细胞和T细胞共刺激表型

Lorek, Daria; Kedzierska, Anna Ewa; Slawek, Anna; Kubik, Paulina; Chelmonska-Soyta, Anna

An AlFu MOF nanoadjuvant functionalized with mannose for potential dendritic-cell targeting and dual TLR9-STING activation

一种经甘露糖功能化的AlFu MOF纳米佐剂,可用于潜在的树突状细胞靶向和双重TLR9-STING激活。

Li, Weixia; Sun, Yang; Guan, Yi; Zhi, Xiao

TLR9 and STING agonists adjuvanted varicella-zoster virus glycoprotein E induced a potent and durable nasal vaccine response

TLR9 和 STING 激动剂佐剂水痘-带状疱疹病毒糖蛋白 E 可诱导强效且持久的鼻内疫苗反应。

Yang, Jing-Xing; Lin, Po-Yen; Tseng, Jen-Chih; Nur Imana, Zaida; Liu, Yi-Ling; Tien, Chih-Feng; Su, Yu-Siang; Tsai, Wan-Ting; Su, Yu-Wen; Chen, Jen-Kun; Huang, Ming-Hsi; Chen, Linyi; Chuang, Tsung-Hsien; Yu, Guann-Yi